Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 5.73B |
| Revenue (ttm) | 1.63B |
| Net Income (ttm) | -424.60M |
| Shares Out | n/a |
| EPS (ttm) | -7.87 |
| PE Ratio | n/a |
| Forward PE | 25.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Average Volume | 61 |
| Open | 146.00 |
| Previous Close | 146.77 |
| Day's Range | 146.00 - 152.08 |
| 52-Week Range | 126.57 - 194.61 |
| Beta | 1.26 |
| RSI | 67.50 |
| Earnings Date | Feb 26, 2026 |
About Masimo
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter... [Read more]
News
Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board
BOSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Clairity, a U.S.-based medical technology company advancing AI-powered breast cancer risk assessment, today announced that its founder, Connie Lehman, MD, PhD...
HARBOR CAPITAL ADVISORS, INC. Sells 333 Shares of Masimo Corp (MASI)
HARBOR CAPITAL ADVISORS, INC. Sells 333 Shares of Masimo Corp (MASI)
Masimo Corp (MASI) Shares Up 3.34% on Jan 15
Masimo Corp (MASI) Shares Up 3.34% on Jan 15
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues
MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.
Masimo Corp at JPMorgan Healthcare Conference Transcript
Masimo Corp at JPMorgan Healthcare Conference Transcript
Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Masimo Corporation (MASI) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 5:15 PM ESTCompany ParticipantsCatherine Szyman - CEO &...
Masimo Posts Preliminary Q4, FY25 Results
(RTTNews) - Masimo Corporation (MASI) on Monday shared preliminary figures for the fourth quarter and full year ending January 3, 2026, showing solid growth in its hospital monitoring segment.
Masimo Announces Select Preliminary 2025 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. Preliminary Fourth Q...
FMS or MASI: Which Is the Better Value Stock Right Now?
FMS vs. MASI: Which Stock Is the Better Value Option?
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pa...
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes
From Taiwan Semiconductor Manufacturing Company Ltd securing a crucial U.S. export license to Masimo Corp. facing quality concerns despite a significant patent win over Apple Inc. , here’s a round-up ...
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse
The past week brought a mixed bag of news, with Apple Inc. (NASDAQ: AAPL) at the center of several stories. The tech giant’s rival, Masimo Corp. (NASDAQ: MASI) , saw its quality score plummet despit...
Masimo Becomes Oversold (MASI)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker
Despite securing a massive $634 million legal victory against Apple Inc. (NASDAQ: AAPL), Masimo Corp. (NASDAQ: MASI) is flashing warning signals in its underlying fundamentals. Check out MASI’s stoc...
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker
Despite securing a massive $634 million legal victory against Apple Inc. (NASDAQ: AAPL), Masimo Corp. (NASDAQ: MASI) is flashing warning signals in its underlying fundamentals.
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium
Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
Apple (AAPL) Wins Court Ruling in Masimo Patent Dispute
Apple (AAPL) Wins Court Ruling in Masimo Patent Dispute
Eight stock picks to play one of the healthiest corners of the market
The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull mar...
Masimo Corporation (MASI) Analyst/Investor Day - Slideshow
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo’s management team provided an update on the company’s long-term strategy . Masimo also provided a detailed l...
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo's management team provided an update on the company's long-term strategy.
Roku To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Needham r...